Developing Drugs For Developing Countries
Author:
Affiliation:
1. Fuqua School of Business, Duke University, in Durham, North Carolina
Publisher
Health Affairs (Project Hope)
Subject
Health Policy
Reference23 articles.
1. A cult pop doc
2. See M. Kremer , “Pharmaceuticals and the Developing World,”Journal of Economic Perspectives16, no. 4 ( 2002 ): 67 –90. Some developers will not hold all patent rights, but the voucher creates a financial incentive for the patent holders to negotiate. John Walsh and colleagues found little empirical basis for claims that patent thickets impede biomedical research. J.P. Walsh, C. Cho, and W.M. Cohen, “View from the Bench: Patents and Material Transfers,”Science309 , no. 5743 ( 2005 ): 2002 –2003.
3. With little revenue at stake, most manufacturers forgo patent protection for essential drugs in developing countries. A. Attaran , “How Do Patents and Economic Policies Affect Access to Essential Medicines in Developing Countries?”Health Affairs23, no. 3 ( 2004 ): 155 –166.
4. Opening Doors to Research: A New Global Patent Regime for Pharmaceuticals
5. Encouraging The Development Of New Vaccines
Cited by 140 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical Benefit and Revenues of Drugs Affected by Rare Pediatric Disease Priority Review Vouchers, 2017-2023;The Journal of Pediatrics;2024-12
2. FDA Breakthrough Therapy Designation Reduced Late-Stage Drug Development Time;Health Affairs;2024-07-01
3. Homeopathic Pyrogenium Ointment as Adjuvant in Treatment of Traumatic and Infected Myiasis by Cochliomyia Hominivorax (Diptera: Calliphoridae) in Sheep: A Case Series;Homeopathy;2024-03-28
4. Analysis of the first ten years of FDA’s rare pediatric disease priority review voucher program: designations, diseases, and drug development;Orphanet Journal of Rare Diseases;2024-02-25
5. European priority review vouchers for neglected disease product development;BMJ Global Health;2024-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3